GlassScriptPhysician profile
Rodney L Yager
NPI 1851321202
$862.39
in general payments reported to CMS, 2019-2025
12 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2024: $221 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $201.98 | 2024-2025 | Breztri, Airsupra |
| Harmony Biosciences LLC | $124.99 | 2021 | |
| Xeris Pharmaceuticals, INC. | $106.40 | 2024-2025 | Gvoke Hypopen |
| Amgen INC. | $79.07 | 2024-2025 | Otezla, Repatha, Repatha |
| Exact Sciences Corporation | $72.70 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $70.09 | 2024-2025 | |
| Verona Pharma, INC. | $65.48 | 2025 | Ohtuvayre |
| Esperion Therapeutics, INC. | $52.09 | 2025 | Nexletol |
| Pfizer INC. | $31.55 | 2025 | |
| Mylan Specialty L.P. | $22.03 | 2024 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $21.29 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.72 | 2025 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Yager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.